ERBB2 and breast cancer: Interestingly, Stender et al. have identified Runx1 as a mediator for ER–DNA interaction in MDA-MB-231 breast cancer cell line (Stender et al. 2010), which stably expresses exogenous ER and is negative for the expression of FOXA1 and HER2.